Mergers and acquisitions in Asia
No one could deny the force behind the momentum of the Asian market and its growing prominence in the area of global M&A. As governments in this highly populated part of the world continue to embrace the capitalist market system, hundreds upon hundreds of millions of new consumers are entering the market, ready to be targeted by the industries who want them to buy their products. This highly lucrative market has managed to hold the attention of firms both local and international looking to get in on mergers and acquisitions. M&A is set to play a pivotal role in the restructuring of a wide array of industries in Asia, reflected in the high M&A deal volume in Asia presented in this statistic. Through the restructure of industry which can be achieved by M&A, the level of competitiveness in this bustling market will increase.
Despite the general high figures and high M&A deal volume in Asia in this time period, the general trend seems to be ebbing towards a declining rate as 2013 progresses. This is most likely due to the fact that the majority of mergers and acquisitions taking place in Asia have been in the pharmaceutical industry and it is this very industry that the rate has been slowing. This slow down is mostly due to the fact that it has been pre-occupied of late with the consolidation of transactions from the previous year, as well as being slightly more cautious with funds, reserving them for the volatile business environment.